Previous 10 | Next 10 |
Acquisition adds TheraTears brand to Company’s leading eye care portfolio Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis Transaction expected to close during fiscal 2Q TARRYTOWN, N.Y., May 27, 202...
Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) traded today at $49.70, eclipsing its 52-week high. So far today approximately 59,000 shares have been exchanged, as compared to an average 30-day volume of 239,000 shares. In the past 52 weeks, shares of Prestige Consumer Healthcare...
Prestige Consumer Healthcare Inc. (NYSE:PBH) traded today at a new 52-week high of $48.95. This new high was reached on below average trading volume as 51,000 shares traded hands, while the average 30-day volume is approximately 257,000 shares. There is potential upside of 1.5% for share...
Prestige Consumer Healthcare Inc. (PBH) Q4 2021 Earnings Conference Call May 6, 2021 08:30 ET Company Participants Philip Terpolilli - Vice President, Investor Relations and Treasury Ron Lombardi - Chairman, President and Chief Executive Officer Christine Sacco - Chief Financial Officer Confe...
The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Prestige Consumer Healthcare Inc (NYSE: PBH) Q4 2021 Earnings Call May 7, 2021 , 8:30 p.m. ET Operator Continue reading For further details see: Prestige Consumer Healthcare Inc (PBH) Q4 2021 Earnings Call T...
Prestige Consumer Healthcare (PBH): Q4 Non-GAAP EPS of $0.79 beats by $0.01; GAAP EPS of $0.70 misses by $0.09.Revenue of $237.8M (-5.3% Y/Y) beats by $7.21M.Provides Full-Year Fiscal 2022 Outlook for Revenue and Earnings Per Share of $957 to $962 Million ($936.2M consensus) and $3.58 or More...
Company Exceeds Full Year 2021 Guidance for Revenue, Adjusted EPS and Free Cash Flow Revenue was $237.8 Million in Q4 and $943.4 in Full-Year Fiscal 2021 Record Diluted EPS of $3.25 for Full-Year Fiscal 2021 Net Cash Provided by Operating Activities for Fiscal 2021 of $235.6...
TARRYTOWN, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 fourth quarter and year-end earnings release on Thursday, May 6, 2021 before the opening of the market. The Company will host a conference call...
Prestige Consumer Healthcare (PBH) prices an upsized offering of $600M in aggregate principal amount of 3.750% senior notes due 2031 in a private offering. The sale of the notes is expected to be completed on or about March 1, 2021. Net proceeds from the offering, together with cash on h...
News, Short Squeeze, Breakout and More Instantly...
Prestige Consumer Healthcare Inc. Company Name:
PBH Stock Symbol:
NYSE Market:
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding Currency Diluted EPS of $1.02 for Q2, ahead of expectations Reduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7x Reaffirming Full-Year Fiscal 2023 Revenue an...
TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discu...
Presentation Times and Weblinks Released for Over 100 Presenting Companies Wednesday and Thursday, September 21-22, 2022 NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-...